JP4201091B1 - Moisturizer, anti-aging agent, antioxidant and external preparation for skin - Google Patents
Moisturizer, anti-aging agent, antioxidant and external preparation for skin Download PDFInfo
- Publication number
- JP4201091B1 JP4201091B1 JP2008145463A JP2008145463A JP4201091B1 JP 4201091 B1 JP4201091 B1 JP 4201091B1 JP 2008145463 A JP2008145463 A JP 2008145463A JP 2008145463 A JP2008145463 A JP 2008145463A JP 4201091 B1 JP4201091 B1 JP 4201091B1
- Authority
- JP
- Japan
- Prior art keywords
- extract
- genus
- added
- skin
- antioxidant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 19
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 18
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 17
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 239000004909 Moisturizer Substances 0.000 title abstract description 10
- 230000001333 moisturizer Effects 0.000 title abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 55
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 13
- 239000004480 active ingredient Substances 0.000 claims description 9
- 235000013305 food Nutrition 0.000 abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 238000004519 manufacturing process Methods 0.000 description 22
- 241000196324 Embryophyta Species 0.000 description 19
- 238000000605 extraction Methods 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- 239000012071 phase Substances 0.000 description 17
- 229940060184 oil ingredients Drugs 0.000 description 16
- 239000003921 oil Substances 0.000 description 15
- 239000008213 purified water Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 235000019441 ethanol Nutrition 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000003205 fragrance Substances 0.000 description 11
- 238000010438 heat treatment Methods 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 238000004945 emulsification Methods 0.000 description 9
- -1 ethylene, propylene, ethanol Chemical class 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229920002674 hyaluronan Polymers 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- 102000011782 Keratins Human genes 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 241000733302 Lysichiton Species 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010040954 Skin wrinkling Diseases 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000001587 sorbitan monostearate Substances 0.000 description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 description 3
- 229940035048 sorbitan monostearate Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241001136126 Symplocarpus foetidus Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 108010093894 Xanthine oxidase Proteins 0.000 description 2
- 102100033220 Xanthine oxidase Human genes 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 235000019866 hydrogenated palm kernel oil Nutrition 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 238000000035 BCA protein assay Methods 0.000 description 1
- 101000645291 Bos taurus Metalloproteinase inhibitor 2 Proteins 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229940122097 Collagenase inhibitor Drugs 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000219428 Fagaceae Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000519079 Hara hara Species 0.000 description 1
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241001317538 Symplocarpus nipponicus Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 150000001867 cobalamins Chemical class 0.000 description 1
- 229940010007 cobalamins Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 239000002442 collagenase inhibitor Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- JUJBNYBVVQSIOU-UHFFFAOYSA-M sodium;4-[2-(4-iodophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=N1 JUJBNYBVVQSIOU-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
【課題】皮膚外用剤や飲食品などの分野に幅広く応用が可能な保湿剤、抗老化剤、抗酸化剤を提供する。
【解決手段】ザゼンソウ属植物より選ばれる1種又は2種以上の植物の抽出物を有効成分とする保湿剤、抗老化剤、抗酸化剤及び皮膚外用剤。
【選択図】 なしThe present invention provides a moisturizer, an anti-aging agent, and an antioxidant that can be widely applied in the field of external preparations for skin and foods and drinks.
[MEANS FOR SOLVING PROBLEMS] A moisturizing agent, an anti-aging agent, an antioxidant and an external preparation for skin, each comprising an extract of one or more plants selected from plants of the genus Genus.
[Selection figure] None
Description
本発明は、保湿剤、抗老化剤、抗酸化剤及び皮膚外用剤に関する。さらに詳しくは、ザゼンソウ属植物より選ばれる1種又は2種以上の植物の抽出物を有効成分とする保湿剤、抗老化剤、抗酸化剤及び皮膚外用剤に関する。 The present invention relates to a humectant, an anti-aging agent, an antioxidant and a skin external preparation. More specifically, the present invention relates to a moisturizer, an anti-aging agent, an antioxidant and an external preparation for skin, each of which contains an extract of one or two or more plants selected from the genus Zazensou.
加齢に伴う皮膚の弾性低下及びシワといった老化症状の原因として、細胞機能低下、コラーゲン等の細胞外マトリックス成分の減少や変性、及び細胞の酸化障害等が挙げられる。このような老化症状を防止・改善するために、従来、様々な有効成分の検索及び配合検討がなされてきた。細胞賦活剤としては、ポンカンのエッセンス(特許文献1参照)、コラゲナーゼ阻害剤としては、ジカルボン酸(特許文献2参照)、コラーゲン産生促進剤としては、ブナ科ブナ属植物の木の芽からの抽出物(特許文献3参照)、抗酸化剤としてはサルオガセ科サルオガセ属植物の抽出物(特許文献4参照)が知られている。ザゼンソウ属植物を皮膚外用剤に用いることは、これまで知られていなかった。 Causes of aging symptoms such as skin elasticity reduction and wrinkles with aging include decreased cell function, decreased or degenerated extracellular matrix components such as collagen, and oxidative damage of cells. In order to prevent and ameliorate such aging symptoms, various active ingredients have been searched and compounded in the past. As a cell activator, the essence of Ponkan (see Patent Document 1), as a collagenase inhibitor, as dicarboxylic acid (see Patent Document 2), as a collagen production promoter, an extract from a bud of a beech family, As an antioxidant, an extract of a plant belonging to the genus Salogaceae (see Patent Document 4) is known. The use of genus genus plants for skin external preparations has not been known so far.
天然由来成分は、様々な薬理作用や美容効果を有することが知られ、これまでにも多数の植物や菌類などが皮膚外用剤や飲食品などの分野に幅広く応用されている。しかし、天然由来成分の中には未だにその効果が知られていないものも数多く存在し、優れた保湿作用、抗老化作用、あるいは抗酸化作用を有する有効成分の開発が期待されていた。本発明は、このような有効成分を見出すためになされたものであり、皮膚外用剤や飲食品などの分野に幅広く応用が可能な保湿剤、抗老化剤、抗酸化剤を提供することを課題とする。 Naturally-derived components are known to have various pharmacological and cosmetic effects, and so far many plants and fungi have been widely applied to fields such as external preparations for skin and foods and drinks. However, there are many naturally-derived ingredients whose effects are not yet known, and the development of an effective ingredient having an excellent moisturizing action, anti-aging action or antioxidant action has been expected. The present invention has been made in order to find such an active ingredient, and it is an object to provide a moisturizer, an anti-aging agent, and an antioxidant that can be widely applied to fields such as external preparations for skin and foods and drinks. And
本発明者らは、上記の課題を解決するために、保湿作用、抗老化作用及び、抗酸化作用に関して、天然由来の種々の物質について検討を行った。その結果、ザゼンソウ属植物より選ばれる1種又は2種以上の植物の抽出物に優れた保湿作用、抗老化作用、抗酸化作用を見出し、さらに検討を重ね、本発明を完成するに至った。 In order to solve the above-mentioned problems, the present inventors have studied various naturally-derived substances with respect to moisturizing action, anti-aging action, and antioxidant action. As a result, an excellent moisturizing action, anti-aging action, and antioxidant action were found in the extract of one or more plants selected from the genus Genus, and further studies were made to complete the present invention.
すなわち、本発明は、ザゼンソウ属植物より選ばれる1種又は2種以上の植物の抽出物を有効成分とする保湿剤、抗老化剤、抗酸化剤及び皮膚外用剤に関する。 That is, the present invention relates to a moisturizing agent, an anti-aging agent, an antioxidant and an external preparation for skin, each of which contains an extract of one or more plants selected from the genus Genus.
本発明によれば、優れた効果を有する保湿剤、抗老化剤、抗酸化剤を提供することができる。また、これらを皮膚外用剤や食品に配合することにより、シワ、タルミ、肌のハリの低下、小ジワ、乾燥など様々な皮膚症状の防止・改善に優れた効果を発揮する組成物を提供することができる。 According to the present invention, it is possible to provide a moisturizer, an anti-aging agent, and an antioxidant having excellent effects. In addition, by blending these with topical skin preparations and foods, a composition that exhibits an excellent effect in preventing and improving various skin symptoms such as wrinkles, tarmi, reduction of skin firmness, wrinkles, and dryness is provided. be able to.
本発明の原料として用いられる植物は、サトイモ科(Araceae)ザゼンソウ属(Symplocarpus)の植物であればよい。ザゼンソウ属植物としては、ザゼンソウ(Symplocarpus foetidus Nutt.var.Latissimus(Makino)H.Hara)、ヒメザゼンソウ(Symplocarpus nipponicus Makino)などが知られている。 The plant used as a raw material of the present invention may be a plant of the genus Araceae and Symplocarp . The skunk cabbage plants of the genus, skunk cabbage (Symplocarpus foetidus Nutt.var. Latissimus (Makino ) H.Hara), such as Himezazensou (Symplocarpus nipponicus Makino) is known.
本発明に用いられる原料となる植物は、ザゼンソウ属植物であれば特に限定されないが、入手が比較的容易なことや有効性などの理由から、ザゼンソウ(Symplocarpus foetidus Nutt.var.Latissimus(Makino)H.Hara)を用いることが好ましい。 Plants as a raw material used in the present invention is not particularly limited as long as skunk cabbage plant of the genus, from reasons such as availability relative ease and effectiveness, skunk cabbage (Symplocarpus foetidus Nutt.var. Latissimus (Makino ) H .Hara) is preferably used.
本発明におけるザゼンソウ属植物の抽出物には、ザゼンソウ属植物の原体や乾燥物も抽出物に含まれるが、各種溶媒を用いて抽出した抽出物を用いるのが好ましい。抽出には、ザゼンソウ属植物の葉、仏炎苞、花、種子、根、茎、芽などのいずれの部位を用いても構わないが、本発明の有効性の点から、花、仏炎苞を含む、開花期の地上部位を用いるとよい。抽出の際は、生のまま用いてもよいが、抽出効果を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが好ましい。抽出は、抽出溶媒に浸漬するか、超臨界流体や亜臨界流体を用いた抽出方法でも行うことができる。抽出効果を上げるため、攪拌や抽出溶媒中でホモジナイズしてもよい。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが適切である。抽出時間は抽出溶媒の種類や抽出温度によっても異なるが、1時間〜14日間程度とするのが適切である。 The extract of the genus genus plant in the present invention includes the active substance and dried product of the genus genus plant, but it is preferable to use an extract extracted with various solvents. For extraction, any part of the leaves of genus genus plant, Buddha buds, flowers, seeds, roots, stems, buds, etc. may be used. From the viewpoint of the effectiveness of the present invention, flowers, Buddha buds are used. It is good to use the ground part of the flowering period containing In the extraction, the raw material may be used as it is, but considering the extraction effect, it is preferable to perform the extraction after performing processing such as shredding, drying, and pulverization. The extraction can be performed by immersing in an extraction solvent or by an extraction method using a supercritical fluid or a subcritical fluid. In order to increase the extraction effect, homogenization may be performed in stirring or an extraction solvent. The extraction temperature is suitably about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but it is appropriate to set it to about 1 hour to 14 days.
抽出溶媒としては、水の他、メタノール、エタノール、プロパノール、イソプロパノール等の低級アルコール、1,3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、グリセリン等の多価アルコール、エチルエーテル、プロピルエーテル等のエーテル類、酢酸ブチル、酢酸エチル等のエステル類、アセトン、エチルメチルケトン等のケトン類などの溶媒を用いることができ、これらより1種又は2種以上を選択して用いる。また、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等を用いてもよい。さらに、水や二酸化炭素、エチレン、プロピレン、エタノール、メタノール、アンモニアなどの1種又は2種以上の超臨界流体や亜臨界流体を用いてもよい。これらの抽出溶媒の中でも本発明の効果の点から、水及びエタノールから選択される1種又は2種を用いることが好ましい。 Extraction solvents include water, lower alcohols such as methanol, ethanol, propanol, and isopropanol, polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol, and glycerin, and ethers such as ethyl ether and propyl ether. And solvents such as esters such as butyl acetate and ethyl acetate, and ketones such as acetone and ethyl methyl ketone can be used, and one or more of these can be selected and used. Further, physiological saline, phosphate buffer, phosphate buffered saline, or the like may be used. Furthermore, you may use 1 type, or 2 or more types of supercritical fluids and subcritical fluids, such as water, a carbon dioxide, ethylene, propylene, ethanol, methanol, ammonia. Among these extraction solvents, it is preferable to use one or two selected from water and ethanol from the viewpoint of the effect of the present invention.
ザゼンソウ属植物の上記溶媒による抽出物は、そのままでも使用することができるが、濃縮、乾固した物を水や極性溶媒に再度溶解して使用することもでき、これらの生理作用を損なわない範囲で脱色、脱臭、脱塩等の精製処理やカラムクロマトグラフィー等による分画処理を行った後に用いてもよい。ザゼンソウ属植物の前記抽出物やその処理物及び分画物は、各処理及び分画後に凍結乾燥し、用時に溶解して用いることもできる。 Extracts from the above-mentioned genus genus plants can be used as they are, but concentrated and dried solids can be used by re-dissolving them in water or polar solvents, and their physiological effects are not impaired. It may be used after performing purification treatment such as decolorization, deodorization, and desalting, and fractionation treatment by column chromatography. The said extract of a genus genus genus, its processed material, and a fraction can also be used after freeze-drying after each process and fractionation, and melt | dissolving at the time of use.
ザゼンソウ属植物の抽出物を有効成分とする保湿剤は、皮膚や毛髪に対して優れた保湿作用を発揮し、特に皮膚に対する保湿効果が高い。 A moisturizing agent comprising an extract of a genus genus plant as an active ingredient exhibits an excellent moisturizing action on the skin and hair, and has a particularly high moisturizing effect on the skin.
ザゼンソウ属植物の抽出物を有効成分とする抗老化剤は、優れたヒアルロン酸産生促進作用を有し、老化症状の防止改善に優れた効果を発揮する。 An anti-aging agent comprising an extract of a genus genus plant as an active ingredient has an excellent hyaluronic acid production promoting action, and exhibits an excellent effect in preventing and improving aging symptoms.
ザゼンソウ属植物の抽出物を有効成分とする抗酸化剤は、優れたフリーラジカル消去効果、およびスーパーオキサイドアニオンの消去効果を有し、皮膚の光老化等を防止して、優れた抗酸化作用を発揮する。 Antioxidants containing extracts of genus genus plant as an active ingredient have excellent free radical scavenging effect and superoxide anion scavenging effect, prevent photo-aging of skin, etc., and have excellent antioxidant action Demonstrate.
ザゼンソウ属植物の抽出物は、優れた保湿作用、抗老化作用、及び抗酸化作用を有し、保湿剤、抗老化剤、抗酸化剤及び皮膚外用剤として利用することができる。また、ザゼンソウ属植物の抽出物を有効成分とする保湿剤、抗老化剤、及び抗酸化剤は、皮膚に外用する外用組成物だけでなく、毛髪に利用することや経口摂取も可能であり、食品、飲料、あるいは医薬品など幅広く応用することが可能である。 The extract of the genus genus plant has excellent moisturizing action, anti-aging action, and antioxidant action, and can be used as a moisturizing agent, anti-aging agent, antioxidant, and skin external preparation. In addition, moisturizers, anti-aging agents, and antioxidants containing extracts of the genus genus genus as active ingredients can be used not only for external use on the skin, but also for hair and can be taken orally. It can be widely applied to food, beverages, pharmaceuticals, etc.
ザゼンソウ属植物の抽出物を皮膚外用剤や食品に配合する際の配合量は、皮膚外用剤や食品の種類や使用目的等によって調整することができるが、効果や安定性などの点から、全量に対して、0.0001〜50.0質量%が好ましく、より好ましくは、0.001〜20.0質量%である。 The amount of the extract of the genus genus plant can be adjusted depending on the type of skin external preparation and food and the purpose of use, etc. The content is preferably 0.0001 to 50.0% by mass, more preferably 0.001 to 20.0% by mass.
ザゼンソウ属植物の抽出物を配合する皮膚外用剤の剤型は任意であり、例えば、ローションなどの可溶化系、クリームや乳液などの乳化系、カラミンローション等の分散系として提供することができる。さらに、噴射剤と共に充填したエアゾール、リップスティック、ファンデーションなどの種々の剤型で提供することもできる。 The dosage form of the external preparation for skin containing the extract of the genus genus genus is arbitrary. For example, it can be provided as a solubilizing system such as lotion, an emulsifying system such as cream or emulsion, or a dispersing system such as calamine lotion. Further, it can be provided in various dosage forms such as aerosol, lipstick, and foundation filled with a propellant.
なお、上記抽出物を配合する皮膚外用剤には、これらの抽出物の他に必要に応じて、通常医薬品、医薬部外品、皮膚化粧料、毛髪用化粧料及び洗浄料に配合される、油性成分,保湿剤,粉体,色素,乳化剤,可溶化剤,洗浄剤,紫外線吸収剤,増粘剤,薬剤,香料,樹脂,防菌防黴剤,アルコール類等を適宜配合することができる。また、本発明の効果を損なわない範囲において、他の保湿剤、抗老化剤、美白剤、抗炎症剤、あるいは抗酸化剤との併用も可能である。 In addition, the external preparation for skin blended with the above extract is usually blended with pharmaceuticals, quasi-drugs, skin cosmetics, hair cosmetics, and cleansing agents as needed in addition to these extracts. Oily ingredients, moisturizers, powders, pigments, emulsifiers, solubilizers, detergents, UV absorbers, thickeners, drugs, fragrances, resins, antibacterial / antifungal agents, alcohols, etc. can be added as appropriate. . In addition, other moisturizers, anti-aging agents, whitening agents, anti-inflammatory agents, or antioxidants can be used in combination as long as the effects of the present invention are not impaired.
また、ザゼンソウ属植物の抽出物を配合する食品の剤型は任意であるが、粉末剤、顆粒剤、カプセル剤、液剤などの種々の剤型で提供することもでき、必要に応じて、医薬品・医薬部外品・食品などに配合される、油性成分、保湿剤、粉体、乳化剤、可溶化剤、増粘剤、薬剤、香料、防菌防黴剤、アルコール類、砂糖、練乳、小麦粉、食塩、ブドウ糖、鶏卵、バター、マーガリン、水飴、カルシウム、鉄分、調味料、香辛料、ビタミンA及びそれらの誘導体、カロテノイド類、リボフラビン及びその誘導体、ビタミンB類及びそれらの塩若しくは誘導体、アスコルビン酸及びその誘導体、コバラミン類、ビタミンE及びそれらの誘導体、ビタミンK、アデノシン及びその誘導体、フラボノイド類及びタンニン類を配合することもできる。さらに、本発明の効果を損なわない範囲において、他の保湿剤、抗老化剤、美白剤、抗炎症剤、あるいは抗酸化剤との併用も可能である。 Moreover, the dosage form of the food containing the extract of the genus genus genus is arbitrary, but it can be provided in various dosage forms such as powders, granules, capsules, liquids, etc.・ Oil ingredients, moisturizers, powders, emulsifiers, solubilizers, thickeners, drugs, fragrances, antibacterial and antifungal agents, alcohols, sugar, condensed milk, wheat flour Salt, glucose, chicken eggs, butter, margarine, starch syrup, calcium, iron, seasonings, spices, vitamin A and derivatives thereof, carotenoids, riboflavin and derivatives thereof, vitamin B and salts or derivatives thereof, ascorbic acid and Derivatives thereof, cobalamins, vitamin E and derivatives thereof, vitamin K, adenosine and derivatives thereof, flavonoids and tannins can also be blended. Furthermore, it can be used in combination with other moisturizers, anti-aging agents, whitening agents, anti-inflammatory agents, or antioxidants as long as the effects of the present invention are not impaired.
以下に、ザゼンソウ属植物の抽出物の製造例、各作用を評価するための試験、皮膚外用剤や食品としての処方例、使用試験について詳細に説明するが、本発明の技術的範囲はこれによってなんら限定されるものではない。 In the following, production examples of extracts of genus genus genus plants, tests for evaluating each action, formulation examples as external preparations for skin and foods, and use tests will be described in detail, but the technical scope of the present invention is based on this. It is not limited at all.
[製造方法1]
ザゼンソウの開花期の地上部位を乾燥させて粉砕し、サンプル質量の20倍量の50質量%エタノール水溶液を加え、室温で攪拌しながら2時間抽出した。得られた抽出液を濾過して不溶物を取り除き、減圧濃縮後、凍結乾燥を行って、抽出物1を得た。
[Production Method 1]
The ground part of the flowering season of sensou was dried and pulverized, and a 50 mass% aqueous ethanol solution 20 times the mass of the sample was added, followed by extraction with stirring at room temperature for 2 hours. The obtained extract was filtered to remove insolubles, concentrated under reduced pressure, and then freeze-dried to obtain extract 1.
[製造方法2]
ザゼンソウの開花期の地上部位を乾燥させて粉砕し、サンプル質量の20倍量の精製水を加え、20分間、120℃に加温して抽出した。得られた抽出液から、吸引濾過により不溶物を取り除いた後、凍結乾燥を行って、抽出物2を得た。
[Production Method 2]
The ground part of the flowering season of zenithou was dried and pulverized, and purified water in an amount 20 times the mass of the sample was added, followed by heating to 120 ° C. for 20 minutes for extraction. From the obtained extract, insolubles were removed by suction filtration, and then lyophilized to obtain Extract 2.
<保湿効果の評価>
表1に示した試料(実施例、比較例)を前腕部、3×4cm2 の範囲に24μL塗布し、塗布前、塗布後15、30、60、120分の角質水分量を測定した。角質水分量は、SKICON−200(アイ・ビイ・エス株式会社製)を用い、各塗布部位から5ポイントずつの角質水分量を測定した。5ポイントの測定値の平均値を角質水分量とし、塗布前の角質水分量を1とした相対値で表2に示した。比較例と実施例の間で有意差検定を行い、5%の確率で有意差が認められたものは「*」、1%の確率で有意差が認められたものは「**」を表2に付した。
<Evaluation of moisturizing effect>
24 μL of the samples shown in Table 1 (Examples and Comparative Examples) were applied to the forearm, 3 × 4 cm 2 range, and the keratin moisture content was measured before application, 15, 30, 60, and 120 minutes after application. The keratin water content was measured by using SKICON-200 (manufactured by IBI S Co., Ltd.) and measuring the keratin water content by 5 points from each application site. Table 2 shows the relative values with the average value of the five-point measurement values as the keratin water content and the keratin water content before application as 1. A significant difference test was performed between the comparative example and the example, and “*” indicates a significant difference with a probability of 5%, and “**” indicates a significant difference with a probability of 1%. It was attached to 2.
表2より明らかなように、ザゼンソウエキスを添加した場合には、優れた保湿効果が認められた。 As is apparent from Table 2, when the sensation extract was added, an excellent moisturizing effect was observed.
<DPPHラジカル消去による抗酸化作用の評価>
50質量%エタノール水溶液を用いて、表3に示す試料濃度となるように抽出物1の溶液を調整し、96ウェルマイクロプレートに100μLずつ添加した。そこへ、0.2mMの1,1−ジフェニル−2−ピクリルヒドラジル(DPPH)エタノール溶液を100μLずつ添加し、よく混合後、室温、暗所にて24時間静置した。最後に、DPPHラジカルに由来する516nmの吸光度を測定した。抽出物1を添加しなかった場合の吸光度を(A)、抽出物1を添加した場合の吸光度を(B)としたとき、DPPHラジカルの消去率を次式より求めた。ラジカル消去率={1−(B)/(A)}×100 結果を表3に示す。
<Evaluation of antioxidant effect by scavenging DPPH radical>
The extract 1 solution was adjusted to a sample concentration shown in Table 3 using a 50% by mass aqueous ethanol solution, and 100 μL was added to each 96-well microplate. Thereto, 100 μL each of 0.2 mM 1,1-diphenyl-2-picrylhydrazyl (DPPH) ethanol solution was added, mixed well, and allowed to stand in the dark at room temperature for 24 hours. Finally, the absorbance at 516 nm derived from the DPPH radical was measured. The extinction rate of the DPPH radical was calculated from the following equation, where (A) was the absorbance when no extract 1 was added and (B) was the absorbance when extract 1 was added. Radical scavenging rate = {1- (B) / (A)} × 100 Table 3 shows the results.
表3より明らかなように、ザゼンソウ属植物の抽出物を添加した場合には、優れたDPPHラジカル消去効果が認められた。 As is apparent from Table 3, when an extract of the genus Pachyderma was added, an excellent DPPH radical scavenging effect was observed.
<SOD様活性評価(スーパーオキサイドアニオン消去能評価)>
0.25mMテトラゾリウム塩(WST−1)および1mMハイポキサンチン(Hypoxanthine)を含むハンクス(HANK’S)(+)溶液75μLに、HANK’S(+)溶液により表4に示す各試料濃度に調製した抽出物2の溶液25μLを添加した。さらに、キサンチンオキシダーゼ(Xanthine Oxidase)25μL(0.0075Units)を添加し、37℃、15分間反応させた後、450nmの吸光度を測定した。抽出物2の溶液に代えてHANK’S(+)溶液のみを添加した場合の吸光度を(A)、抽出物2の溶液を添加した場合の吸光度を(B)としたときの、スーパーオキサイドアニオン消去率は次式に定義される。消去率(%)={1−(B)/(A)}×100 得られた結果を表4に示す。
<SOD-like activity evaluation (superoxide anion scavenging ability evaluation)>
A HANK'S (+) solution (75 μL) containing 0.25 mM tetrazolium salt (WST-1) and 1 mM hypoxanthine was prepared with each sample concentration shown in Table 4 using the HANK'S (+) solution. 25 μL of Extract 2 solution was added. Furthermore, xanthine oxidase (Xanthine Oxidase) 25 microliters (0.0075Units) was added, and after making it react at 37 degreeC for 15 minute (s), the light absorbency of 450 nm was measured. Superoxide anion when (A) is the absorbance when only the HANK'S (+) solution is added instead of the solution of Extract 2 and (B) is the absorbance when the solution of Extract 2 is added The erasure rate is defined by the following equation. Erase rate (%) = {1- (B) / (A)} × 100 Table 4 shows the results obtained.
表4より明らかなように、ザゼンソウ属植物の抽出物を添加した場合には、優れたスーパーオキサイドアニオン消去効果が認められた。 As is apparent from Table 4, when an extract of the genus Pachyderma was added, an excellent superoxide anion scavenging effect was observed.
<ヒト真皮線維芽細胞ヒアルロン酸産生作用の評価>
正常ヒト真皮線維芽細胞を1ウェル当り2.0×104個となるように96ウェルマイクロプレートに播種した。播種培地には、ダルベッコ改変イーグル培地(DMEM)に5質量%のウシ胎児血清(FBS)を添加したものを用いた。24時間後、0.5%FBS添加DMEM培地にて各濃度に調製したサンプル培養液に交換し、さらに5日間培養した。培養上清中に分泌されたヒアルロン酸定量はプロテオグリカンを用いた間接ELISA法を用いた。間接ELISA法としては、96ウェルマイクロプレートにヒアルロン酸をコーティングし、一次抗体として抗ケラタン硫酸溶液を、二次抗体として抗マウスIgG抗体を用いた。最後は標識されたペルオキシダーゼに対し2,2−アジノビス(3−エチルベンゾチアゾリン−6−スルホン酸)ジアンモニウム塩(ABTS)及び過酸化水素を各ウェルに添加し、反応させた後、マイクロプレートリーダーにて405nmの吸光度を測定した。PIERCE社製BCA Protein Assay Kitにて各ウェルのタンパク量を測定し単位タンパク量当りのヒアルロン酸産生量を求めた。得られた結果を表5に示す。
<Evaluation of human dermal fibroblast hyaluronic acid production action>
Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. The seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS). After 24 hours, the medium was replaced with a sample culture solution adjusted to each concentration in a DMEM medium supplemented with 0.5% FBS, and further cultured for 5 days. The indirect ELISA method using proteoglycan was used for the determination of hyaluronic acid secreted into the culture supernatant. As an indirect ELISA method, a 96-well microplate was coated with hyaluronic acid, an anti-keratan sulfate solution was used as a primary antibody, and an anti-mouse IgG antibody was used as a secondary antibody. Finally, 2,2-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) and hydrogen peroxide were added to each peroxidase and allowed to react with each well. Absorbance was measured at 405 nm. The amount of protein in each well was measured with PIERCE BCA Protein Assay Kit to determine the amount of hyaluronic acid produced per unit protein. The results obtained are shown in Table 5.
表5より明らかなように、ザゼンソウ属植物の抽出物を添加した場合には、優れたヒアルロン酸産生促進作用が認められた。 As is apparent from Table 5, when an extract of the genus Pachyderma was added, an excellent hyaluronic acid production promoting effect was observed.
続いて、本発明に係るザゼンソウ属植物の抽出物を配合した組成物として、皮膚外用剤と食品の処方例を示す。 Then, the formulation example of a skin external preparation and a foodstuff is shown as a composition which mix | blended the extract of the genus Genus according to this invention.
[処方例1]乳液
(1)スクワラン 10.0(質量%)
(2)メチルフェニルポリシロキサン 4.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)モノステアリン酸ポリオキシエチレン
ソルビタン(20E.O.) 1.3
(6)モノステアリン酸ソルビタン 1.0
(7)グリセリン 4.0
(8)パラオキシ安息香酸メチル 0.1
(9)カルボキシビニルポリマー 0.15
(10)精製水 53.85
(11)アルギニン(1質量%水溶液) 20.0
(12)抽出物1 5.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、冷却を開始し、(11)と(12)を順次加え、均一に混合する。
[Formulation Example 1] Emulsion (1) Squalane 10.0 (mass%)
(2) Methylphenylpolysiloxane 4.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Polyoxyethylene monostearate
Sorbitan (20E.O.) 1.3
(6) Sorbitan monostearate 1.0
(7) Glycerin 4.0
(8) Methyl paraoxybenzoate 0.1
(9) Carboxyvinyl polymer 0.15
(10) Purified water 53.85
(11) Arginine (1% by weight aqueous solution) 20.0
(12) Extract 1 5.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. After the emulsification, cooling is started, and (11) and (12) are sequentially added and mixed uniformly.
[処方例2]化粧水
(1)エタノール 15.0(質量%)
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.3
(3)香料 0.1
(4)精製水 78.38
(5)クエン酸 0.02
(6)クエン酸ナトリウム 0.1
(7)グリセリン 1.0
(8)ヒドロキシエチルセルロース 0.1
(9)抽出物1 5.0
製法:(1)に(2)及び(3)を溶解する。溶解後、(4)〜(8)を順次添加した後、十分に攪拌し、(9)を加え、均一に混合する。
[Prescription Example 2] Lotion (1) Ethanol 15.0 (mass%)
(2) Polyoxyethylene (40E.O.) hydrogenated castor oil 0.3
(3) Fragrance 0.1
(4) Purified water 78.38
(5) Citric acid 0.02
(6) Sodium citrate 0.1
(7) Glycerin 1.0
(8) Hydroxyethyl cellulose 0.1
(9) Extract 1 5.0
Production method: (2) and (3) are dissolved in (1). After dissolution, (4) to (8) are sequentially added, and then sufficiently stirred, (9) is added and mixed uniformly.
[処方例3]クリーム
(1)スクワラン 10.0(質量%)
(2)ステアリン酸 2.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)セタノール 3.6
(6)親油型モノステアリン酸グリセリン 2.0
(7)グリセリン 10.0
(8)パラオキシ安息香酸メチル 0.1
(9)アルギニン(20質量%水溶液) 15.0
(10)精製水 36.7
(11)カルボキシビニルポリマー(1質量%水溶液) 15.0
(12)抽出物2 5.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、(11)を加え、冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Prescription Example 3] Cream (1) Squalane 10.0 (mass%)
(2) Stearic acid 2.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Cetanol 3.6
(6) Lipophilic glyceryl monostearate 2.0
(7) Glycerin 10.0
(8) Methyl paraoxybenzoate 0.1
(9) Arginine (20 mass% aqueous solution) 15.0
(10) Purified water 36.7
(11) Carboxyvinyl polymer (1% by weight aqueous solution) 15.0
(12) Extract 2 5.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. (11) is added after completion | finish of emulsification, cooling is started, (12) is added at 40 degreeC, and it mixes uniformly.
[処方例4]美容液
(1)精製水 27.45(質量%)
(2)グリセリン 10.0
(3)ショ糖脂肪酸エステル 1.3
(4)カルボキシビニルポリマー(1質量%水溶液) 17.5
(5)アルギン酸ナトリウム(1質量%水溶液) 15.0
(6)モノラウリン酸ポリグリセリル 1.0
(7)マカデミアナッツ油脂肪酸フィトステリル 3.0
(8)N−ラウロイル−L−グルタミン酸
ジ(フィトステリル−2−オクチルドデシル) 2.0
(9)硬化パーム油 2.0
(10)スクワラン(オリーブ由来) 1.0
(11)ベヘニルアルコール 0.75
(12)ミツロウ 1.0
(13)ホホバ油 1.0
(14)1,3−ブチレングリコール 10.0
(15)L−アルギニン(10質量%水溶液) 2.0
(16)抽出物1 5.0
製法:(1)〜(6)の水相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(14)の油相成分を混合し、75℃にて加熱溶解する。次いで、上記水相成分に油相成分を添加して予備乳化を行った後、ホモミキサーにて均一に乳化する。乳化終了後に冷却を開始し、50℃にて(15)を加える。さらに40℃まで冷却し、(16)を加え、均一に混合する。
[Formulation Example 4] Cosmetic liquid (1) Purified water 27.45 (mass%)
(2) Glycerin 10.0
(3) Sucrose fatty acid ester 1.3
(4) Carboxyvinyl polymer (1% by weight aqueous solution) 17.5
(5) Sodium alginate (1% by weight aqueous solution) 15.0
(6) Polyglyceryl monolaurate 1.0
(7) Macadamia nut oil fatty acid phytosteryl 3.0
(8) N-lauroyl-L-glutamic acid di (phytosteryl-2-octyldodecyl) 2.0
(9) Hardened palm oil 2.0
(10) Squalane (derived from olive) 1.0
(11) Behenyl alcohol 0.75
(12) Beeswax 1.0
(13) Jojoba oil 1.0
(14) 1,3-butylene glycol 10.0
(15) L-arginine (10% by mass aqueous solution) 2.0
(16) Extract 1 5.0
Production method: The aqueous phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the oil phase components (7) to (14) are mixed and dissolved by heating at 75 ° C. Next, the oil phase component is added to the aqueous phase component and preliminary emulsification is performed, followed by uniform emulsification with a homomixer. Cooling is started after completion of emulsification, and (15) is added at 50 ° C. Cool further to 40 ° C., add (16) and mix evenly.
[処方例5]水性ジェル
(1)カルボキシビニルポリマー 0.5(質量%)
(2)精製水 78.7
(3)水酸化ナトリウム(10質量%水溶液) 0.5
(4)エタノール 10.0
(5)パラオキシ安息香酸メチル 0.1
(6)香料 0.1
(7)抽出物2 10.0
(8)ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.1
製法:(1)を(2)に加え、均一に攪拌した後、(3)を加える。均一に攪拌した後、(4)に予め溶解した(5)を加える。均一に攪拌した後、予め混合しておいた(6)〜(8)を加え、均一に攪拌混合する。
[Formulation Example 5] Aqueous gel (1) Carboxyvinyl polymer 0.5 (mass%)
(2) Purified water 78.7
(3) Sodium hydroxide (10% by mass aqueous solution) 0.5
(4) Ethanol 10.0
(5) Methyl paraoxybenzoate 0.1
(6) Fragrance 0.1
(7) Extract 2 10.0
(8) Polyoxyethylene (60E.O.) hydrogenated castor oil 0.1
Manufacturing method: (1) is added to (2), and after stirring uniformly, (3) is added. After stirring uniformly, (5) previously dissolved in (4) is added. After stirring uniformly, the previously mixed (6) to (8) are added and stirred and mixed uniformly.
[処方例6]クレンジング料
(1)スクワラン 77.0(質量%)
(2)イソステアリン酸ポリオキシエチレングリセリル 15.0
(3)精製水 3.0
(4)抽出物1 5.0
製法:(1)と(2)を均一に溶解する。これに、(3)と(4)を順次加え、均一に混合する。
[Formulation Example 6] Cleansing Fee (1) Squalane 77.0 (mass%)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Purified water 3.0
(4) Extract 1 5.0
Manufacturing method: (1) and (2) are uniformly dissolved. (3) and (4) are sequentially added to this and mixed uniformly.
[処方例7]洗顔フォーム
(1)ステアリン酸 16.0(質量%)
(2)ミリスチン酸 16.0
(3)親油型モノステアリン酸グリセリン 2.0
(4)グリセリン 20.0
(5)水酸化ナトリウム 7.5
(6)ヤシ油脂肪酸アミドプロピルベタイン 1.0
(7)精製水 31.5
(8)抽出物2 6.0
製法:(1)〜(4)の油相成分を80℃にて加熱溶解する。一方(5)〜(7)の水相成分を80℃にて加熱溶解し、油相成分と均一に混合攪拌する。冷却を開始し、40℃にて(8)を加え、均一に混合する。
[Formulation Example 7] Face-wash foam (1) Stearic acid 16.0 (mass%)
(2) Myristic acid 16.0
(3) Lipophilic glyceryl monostearate 2.0
(4) Glycerin 20.0
(5) Sodium hydroxide 7.5
(6) Palm oil fatty acid amidopropyl betaine 1.0
(7) Purified water 31.5
(8) Extract 2 6.0
Production method: The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the water phase components (5) to (7) are heated and dissolved at 80 ° C., and the oil phase components are uniformly mixed and stirred. Cooling is started, and (8) is added at 40 ° C. and mixed uniformly.
[処方例8]メイクアップベースクリーム
(1)スクワラン 10.2(質量%)
(2)セタノール 2.0
(3)グリセリントリ−2−エチルヘキサン酸エステル 2.5
(4)親油型モノステアリン酸グリセリル 1.0
(5)プロピレングリコール 11.0
(6)ショ糖脂肪酸エステル 1.3
(7)精製水 65.4
(8)酸化チタン 1.0
(9)ベンガラ 0.1
(10)黄酸化鉄 0.4
(11)香料 0.1
(12)抽出物2 5.0
製法:(1)〜(4)の油相成分を混合し、75℃にて加熱溶解する。一方、(5)〜(7)の水相成分を混合し、75℃にて加熱溶解し、これに、(8)〜(10)の顔料を加え、ホモミキサーにて均一に分散させる。この水相成分に前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Prescription Example 8] Make-up base cream (1) Squalane 10.2 (mass%)
(2) Cetanol 2.0
(3) Glycerin tri-2-ethylhexanoate 2.5
(4) Lipophilic glyceryl monostearate 1.0
(5) Propylene glycol 11.0
(6) Sucrose fatty acid ester 1.3
(7) Purified water 65.4
(8) Titanium oxide 1.0
(9) Bengala 0.1
(10) Yellow iron oxide 0.4
(11) Fragrance 0.1
(12) Extract 2 5.0
Production method: The oil phase components (1) to (4) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (5) to (7) are mixed and dissolved by heating at 75 ° C., and the pigments (8) to (10) are added thereto and uniformly dispersed with a homomixer. The oil phase component is added to the water phase component and emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.
[処方例9]乳液状ファンデーション
(1)メチルポリシロキサン 2.0(質量%)
(2)スクワラン 5.0
(3)ミリスチン酸オクチルドデシル 5.0
(4)セタノール 1.0
(5)ポリオキシエチレン(20E.O.)
ソルビタンモノステアリン酸エステル 1.3
(6)モノステアリン酸ソルビタン 0.7
(7)1,3−ブチレングリコール 8.0
(8)キサンタンガム 0.1
(9)パラオキシ安息香酸メチル 0.1
(10)精製水 53.6
(11)酸化チタン 9.0
(12)タルク 7.4
(13)ベンガラ 0.5
(14)黄酸化鉄 1.1
(15)黒酸化鉄 0.1
(16)香料 0.1
(17)抽出物2 5.0
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(10)の水相成分を混合し、75℃にて加熱溶解し、これに(11)〜(15)の顔料を加え、ホモミキサーにて均一に分散させる。この水相成分に前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(16)と(17)の成分を順次加え、均一に混合する。
[Prescription Example 9] Emulsion foundation (1) Methylpolysiloxane 2.0 (mass%)
(2) Squalane 5.0
(3) Octyldodecyl myristate 5.0
(4) Cetanol 1.0
(5) Polyoxyethylene (20E.O.)
Sorbitan monostearate 1.3
(6) Sorbitan monostearate 0.7
(7) 1,3-butylene glycol 8.0
(8) Xanthan gum 0.1
(9) Methyl paraoxybenzoate 0.1
(10) Purified water 53.6
(11) Titanium oxide 9.0
(12) Talc 7.4
(13) Bengala 0.5
(14) Yellow iron oxide 1.1
(15) Black iron oxide 0.1
(16) Fragrance 0.1
(17) Extract 2 5.0
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are mixed and dissolved by heating at 75 ° C., and the pigments (11) to (15) are added thereto and uniformly dispersed with a homomixer. The oil phase component is added to the water phase component and emulsified with a homomixer. Cooling is started after the emulsification is completed, and components (16) and (17) are sequentially added at 40 ° C. and mixed uniformly.
[処方例10]油中水型エモリエントクリーム
(1)流動パラフィン 30.0(質量%)
(2)マイクロクリスタリンワックス 2.0
(3)ワセリン 5.0
(4)ジグリセリンオレイン酸エステル 5.0
(5)塩化ナトリウム 1.3
(6)塩化カリウム 0.1
(7)プロピレングリコール 3.0
(8)1,3−ブチレングリコール 5.0
(9)パラオキシ安息香酸メチル 0.1
(10)抽出物2 5.0
(11)精製水 43.4
(12)香料 0.1
製法:(5)と(6)を(11)の一部に溶解して50℃とし、50℃に加熱した(4)に攪拌しながら徐々に加える。これを混合した後、70℃にて加熱溶解した(1)〜(3)に均一に分散する。これに(7)〜(10)を(11)の残部に70℃にて加熱溶解したものを攪拌しながら加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Prescription Example 10] Water-in-oil emollient cream (1) Liquid paraffin 30.0 (mass%)
(2) Microcrystalline wax 2.0
(3) Vaseline 5.0
(4) Diglycerin oleate 5.0
(5) Sodium chloride 1.3
(6) Potassium chloride 0.1
(7) Propylene glycol 3.0
(8) 1,3-butylene glycol 5.0
(9) Methyl paraoxybenzoate 0.1
(10) Extract 2 5.0
(11) Purified water 43.4
(12) Fragrance 0.1
Production method: Dissolve (5) and (6) in a part of (11) to 50 ° C, and gradually add to (4) heated to 50 ° C with stirring. After mixing this, it disperse | distributes uniformly to (1)-(3) heated and melt | dissolved at 70 degreeC. (7) to (10) are added to the remainder of (11) heated and dissolved at 70 ° C. with stirring, and emulsified with a homomixer. Cooling is started after completion of emulsification, and (12) is added at 40 ° C. and mixed uniformly.
[処方例11]パック
(1)精製水 58.9(質量%)
(2)ポリビニルアルコール 12.0
(3)エタノール 17.0
(4)グリセリン 5.0
(5)ポリエチレングリコール(平均分子量1000) 2.0
(6)抽出物1 5.0
(7)香料 0.1
製法:(2)と(3)を混合し、80℃に加温した後、80℃に加温した(1)に溶解する。均一に溶解した後、(4)と(5)を加え、攪拌しながら冷却を開始する。40℃まで冷却し、(6)と(7)を加え、均一に混合する。
[Prescription Example 11] Pack (1) Purified water 58.9 (mass%)
(2) Polyvinyl alcohol 12.0
(3) Ethanol 17.0
(4) Glycerin 5.0
(5) Polyethylene glycol (average molecular weight 1000) 2.0
(6) Extract 1 5.0
(7) Fragrance 0.1
Production method: (2) and (3) are mixed, heated to 80 ° C, and then dissolved in (1) heated to 80 ° C. After uniformly dissolving, add (4) and (5), and start cooling while stirring. Cool to 40 ° C, add (6) and (7) and mix uniformly.
[処方例12]入浴剤
(1)香料 0.3(質量%)
(2)抽出物1 5.0
(3)炭酸水素ナトリウム 46.0
(4)硫酸ナトリウム 48.7
製法:(1)〜(4)を均一に混合する。
[Prescription Example 12] Bath agent (1) Fragrance 0.3 (mass%)
(2) Extract 1 5.0
(3) Sodium bicarbonate 46.0
(4) Sodium sulfate 48.7
Production method: (1) to (4) are mixed uniformly.
[処方例13]ヘアーワックス
(1)ステアリン酸 3.0(質量%)
(2)マイクロクリスタリンワックス 2.0
(3)セチルアルコール 3.0
(4)高重合メチルポリシロキサン 2.0
(5)メチルポリシロキサン 5.0
(6)ポリ(オキシエチレン・オキシプロピレン)
メチルポリシロキサン共重合体 1.0
(7)パラオキシ安息香酸メチル 0.1
(8)1,3−ブチレングリコール 7.5
(9)アルギニン 0.7
(10)精製水 70.6
(11)抽出物2 5.0
(12)香料 0.1
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(10)の水相成分を75℃にて加熱溶解し、前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Prescription Example 13] Hair wax (1) Stearic acid 3.0 (mass%)
(2) Microcrystalline wax 2.0
(3) Cetyl alcohol 3.0
(4) Highly polymerized methylpolysiloxane 2.0
(5) Methylpolysiloxane 5.0
(6) Poly (oxyethylene / oxypropylene)
Methylpolysiloxane copolymer 1.0
(7) Methyl paraoxybenzoate 0.1
(8) 1,3-butylene glycol 7.5
(9) Arginine 0.7
(10) Purified water 70.6
(11) Extract 2 5.0
(12) Fragrance 0.1
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 75 ° C., the oil phase component is added, and the mixture is emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.
[処方例14]ヘアートニック
(1)エタノール 46.0(質量%)
(2)精製水 48.9
(3)抽出物1 5.0
(4)香料 0.1
製法:(1)〜(4)の成分を混合、均一化する。
[Prescription Example 14] Hairtonic (1) Ethanol 46.0 (mass%)
(2) Purified water 48.9
(3) Extract 1 5.0
(4) Fragrance 0.1
Production method: Components (1) to (4) are mixed and homogenized.
[処方例15]飲料
(1)抽出物2 8.0(質量%)
(2)エリスリトール 1.0
(3)クエン酸 0.1
(4)ステビア 0.01
(5)精製水 90.89
製法:(1)〜(5)を均一に混合する。
[Prescription Example 15] Beverage (1) Extract 2 8.0 (mass%)
(2) Erythritol 1.0
(3) Citric acid 0.1
(4) Stevia 0.01
(5) Purified water 90.89
Production method: (1) to (5) are mixed uniformly.
[処方例16]錠剤
(1)抽出物1 0.30(質量部)
(2)還元麦芽糖水飴 0.53
(3)トウモロコシデンプン 0.15
(4)グリセリン脂肪酸エステル 0.02
製法:(1)〜(3)を篩過して混合し、さらに(4)を添加して混合した。打錠機にて打錠を行い、全量300mgの錠剤を得た。
[Prescription Example 16] Tablet (1) Extract 1 0.30 (parts by mass)
(2) Reduced maltose starch syrup 0.53
(3) Corn starch 0.15
(4) Glycerin fatty acid ester 0.02
Production method: (1) to (3) were sieved and mixed, and (4) was further added and mixed. Tableting was performed with a tableting machine to obtain tablets with a total amount of 300 mg.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008145463A JP4201091B1 (en) | 2008-06-03 | 2008-06-03 | Moisturizer, anti-aging agent, antioxidant and external preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008145463A JP4201091B1 (en) | 2008-06-03 | 2008-06-03 | Moisturizer, anti-aging agent, antioxidant and external preparation for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JP4201091B1 true JP4201091B1 (en) | 2008-12-24 |
JP2009292742A JP2009292742A (en) | 2009-12-17 |
Family
ID=40239540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008145463A Active JP4201091B1 (en) | 2008-06-03 | 2008-06-03 | Moisturizer, anti-aging agent, antioxidant and external preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4201091B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102631306A (en) * | 2012-01-09 | 2012-08-15 | 杭州万承志堂国药馆有限公司 | Freckle removing and skin whitening mask containing traditional Chinese medicines |
CN110392566A (en) * | 2018-02-23 | 2019-10-29 | 株式会社 Lg 生活健康 | Wrinkle-improving composition comprising skatole extract or its fraction as active ingredient |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102486012B1 (en) * | 2019-07-02 | 2023-01-05 | 주식회사 엘지생활건강 | Microneedle Comprising Symplocarpus Foetidus Extract |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000247897A (en) * | 1999-02-26 | 2000-09-12 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
JP2002363089A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Lipid peroxide formation inhibitor or cosmetic composition |
JP2002363088A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Elastase activity inhibitor or cosmetic composition |
US10117812B2 (en) * | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
JP5118292B2 (en) * | 2005-06-16 | 2013-01-16 | 株式会社ロッテ | Lipolysis accelerator |
JP5189735B2 (en) * | 2006-01-31 | 2013-04-24 | 株式会社ロッテ | Pili movement activator |
-
2008
- 2008-06-03 JP JP2008145463A patent/JP4201091B1/en active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102631306A (en) * | 2012-01-09 | 2012-08-15 | 杭州万承志堂国药馆有限公司 | Freckle removing and skin whitening mask containing traditional Chinese medicines |
CN110392566A (en) * | 2018-02-23 | 2019-10-29 | 株式会社 Lg 生活健康 | Wrinkle-improving composition comprising skatole extract or its fraction as active ingredient |
EP3756647A4 (en) * | 2018-02-23 | 2021-12-01 | LG Household & Health Care Ltd. | Composition containing skunk cabbage extract or fraction thereof as active ingredient for wrinkle relief |
Also Published As
Publication number | Publication date |
---|---|
JP2009292742A (en) | 2009-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5557414B2 (en) | Moisturizer, cell activator, and whitening agent | |
JP4201091B1 (en) | Moisturizer, anti-aging agent, antioxidant and external preparation for skin | |
JP2010150207A (en) | Moisturizer, anti-aging agent, antioxidant, neutral fat-accumulation inhibitor, skin whitening agent, anti-inflammatory agent, immunostimulator, skin care preparation, oral medication | |
JP5014343B2 (en) | Nemagaridake-containing composition, moisturizer, cell activator, whitening agent and antioxidant | |
JP5306605B2 (en) | Topical skin preparation | |
JP5312731B2 (en) | Topical skin preparation | |
JP5800454B2 (en) | External preparation for skin, oral preparation, antioxidant, anti-aging agent, and immunostimulant | |
JP4799335B2 (en) | Moisturizer, cell activator, collagen production promoter, hyaluronic acid production promoter, antioxidant and neutral fat accumulation inhibitor | |
JP5465037B2 (en) | Anti-aging agent, antioxidant, whitening agent, immunostimulant, external preparation for skin and functional oral composition | |
JP5025201B2 (en) | Moisturizer, anti-aging agent, whitening agent, anti-inflammatory agent, and antioxidant | |
JP5383001B2 (en) | Skin preparations, moisturizers, anti-aging agents, antioxidants, anti-inflammatory agents, whitening agents, and slimming agents | |
JP5062980B2 (en) | Moisturizer, collagen production promoter, whitening agent, antioxidant, and vascular endothelial growth factor production promoter | |
JP5455634B2 (en) | Skin preparations and moisturizers | |
JP4931452B2 (en) | Moisturizer, cell activator, whitening agent, and antioxidant | |
JP4994684B2 (en) | Moisturizer, cell activator, and antioxidant | |
JP4970442B2 (en) | Whitening agent | |
JP5241395B2 (en) | Moisturizer, immunostimulant, anti-aging agent, anti-inflammatory agent, antioxidant, whitening agent | |
JP4515423B2 (en) | Moisturizer, cell activator, and antioxidant | |
JP5656348B2 (en) | Moisturizer, anti-aging agent, antioxidant, immunostimulant, whitening agent, skin external preparation, functional oral composition | |
JP4515425B2 (en) | Moisturizer, cell activator, whitening agent, and antioxidant | |
JP5550929B2 (en) | Moisturizer, anti-aging agent, antioxidant, whitening agent, anti-inflammatory agent, topical skin preparation and functional oral composition | |
JP2007063206A (en) | Neutral fat-accumulation inhibitor | |
JP2009256243A (en) | Humectant, antiaging agent, antioxidant, skin care preparation and functional oral composition | |
JP2011168559A (en) | Antioxidant, anti-inflammatory agent, anti-aging agent, skin care preparation for external use and functional oral composition | |
JP2011225477A (en) | Anti-aging agent, antioxidant, external preparation for skin, and functional oral composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080822 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080924 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4201091 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111017 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111017 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121017 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121017 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131017 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |